Shah Nikita

SEC Form 4 insider
Executive Vice President · Amneal Pharmaceuticals, Inc. ($AMRX)
1 thesis · first seen Aug 13, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d1100%+5.1%+5.1%
3d1100%+5.1%+5.1%
1w1100%+3.6%+3.6%
1m000———
3m000———
6m000———
1y000———

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$AMRXSEC Form 4bearish
Sold 146,403 @ $17.51 avg · $2,563,517 · 2026-08-12

Form 4: Shah Nikita sold AMRX

Shah Nikita (Executive Vice President at Amneal Pharmaceuticals, Inc.) reported an open-market sale of 146,403 shares of AMRX at an average $17.51, roughly $2,563,517, in a Form 4 filed 2026-08-13.

At post $17.27Now $18.71+8.3% since postedas of Sep 18, 4:30 PM ET
1d+5.1%
3d+5.1%
1w+3.6%
1m-1.5%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.